comparemela.com

Latest Breaking News On - Drug monitoring committee - Page 1 : comparemela.com

Chemomab Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update

/PRNewswire/ Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative.

United statesIrina kofflerDale pfostBarbara lindheimWadi morFibrosis drug development summitDrug monitoring committeeLifesci advisorsDrug administrationChemomab therapeutics ltdDevelopment rd expensesStrategic communicationsPrnewswire chemomab therapeutics ltdFibrotic drug development summitUnion world conference on lung healthHost conference call

Chemomab Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update

/PRNewswire/ Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative.

United statesUnited kingdomCity ofIlan vakninIrina kofflerDale pfostBarbara lindheimJill quigleyBristol myers squibbJillm quigleyEuropean congressDrug monitoring committeeLifesci advisorsCompugen ltdChemomab therapeutics ltdSecurities life sciences

vasopharm GmbH Announces Brain Lactate Microdialysate Data from Post Hoc Analyses of Clinical Trials in Traumatic Brain Injury

Ronopterin significantly reduces lactate levels in brain microdialysate from TBI patients reflecting energetic stability and neuroprotection during the early.

Glasgow cityUnited kingdomHarald schmidtStefan wolfJohn stoverUlrich walterDepartment of neurosurgery charitDrug monitoring committeeInternational neurotrauma symposiumNeurosurgery charitChief medical officerPlenary sessionAbstract lectureTraumatic brain injuryMedical schoolClinical biochemistry

vasopharm GmbH Announces Brain Glutamate Microdialysate Data from Post Hoc Analyses of Clinical Trials in Traumatic Brain Injury

Ronopterin significantly reduces glutamate levels measured in brain microdialysate from TBI patients, an important and long sought indicator of biochemical.

Glasgow cityUnited kingdomBaden wübergHarald schmidtAndreas unterbergJohn stoverUlrich walterCarl henrik nordstrDepartment of neurosurgeryDrug monitoring committeeUniversity hospital heidelbergClinical development planOdense university hospitalProfessor andreas unterbergLead investigatorChief medical officer

vasopharm GmbH Announces Post Hoc Analyses of Clinical Trials in Traumatic Brain Injury

/PRNewswire/ vasopharm GmbH ("vasopharm"), a privately-held biopharmaceutical company focusing on novel therapeutics to treat cerebrovascular diseases,.

Glasgow cityUnited kingdomHarald schmidtJohn stoverUlrich walterErich schmutzhardUniversity of innsbruckDrug monitoring committeeClinical development plan for ronopterinClinical development planMedical universityChief investigatorGlasgow outcome scaleUnfavorable outcomeFavorable outcomeGood recovery

vimarsana © 2020. All Rights Reserved.